GENTITAN Trademark

Trademark Overview

On Wednesday, March 15, 2023, a trademark application was filed for GENTITAN with the United States Patent and Trademark Office. The USPTO has given the GENTITAN trademark a serial number of 79369107. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 3, 2025. This trademark is owned by Nanjing Genscript Biotech Co., Ltd.. The GENTITAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technology research in the field of gene synthesis; technology research in the field of gene editing; technology research in the field of DNA chips; research and development of new products for others; scientific laboratory services; medical and scientific research, namely, conducting clinical trials for others; structural and functional analysis of genomes; medical research; medical laboratory services; stem cell research services; research and development services in the field of antibodies; research in the field of physics; biological research and analysis; bacteriological research and analysis; genetic testing for scientific research purposes; biotechnology research; testing of pharmaceuticals; DNA screening for scientific research purposes; biomedical research services; biological cloning services
gentitan

General Information

Serial Number79369107
Word MarkGENTITAN
Filing DateWednesday, March 15, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements

Goods and ServicesTechnology research in the field of gene synthesis; technology research in the field of gene editing; technology research in the field of DNA chips; research and development of new products for others; scientific laboratory services; medical and scientific research, namely, conducting clinical trials for others; structural and functional analysis of genomes; medical research; medical laboratory services; stem cell research services; research and development services in the field of antibodies; research in the field of physics; biological research and analysis; bacteriological research and analysis; genetic testing for scientific research purposes; biotechnology research; testing of pharmaceuticals; DNA screening for scientific research purposes; biomedical research services; biological cloning services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 17, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNanjing Genscript Biotech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN
Party NameNanjing Genscript Biotech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events

Event DateEvent Description
Thursday, May 11, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, May 16, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, May 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 23, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, August 15, 2023ASSIGNED TO EXAMINER
Wednesday, August 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 25, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, August 30, 2023NOTICE OF PUBLICATION
Wednesday, August 30, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, September 18, 2023NOTIFICATION PROCESSED BY IB
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Thursday, September 21, 2023LETTER OF PROTEST EVIDENCE FORWARDED
Monday, September 25, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, September 26, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, October 5, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, October 12, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, January 18, 2024OPPOSITION NOTICE (IB REFUSAL) CREATED
Thursday, January 18, 2024OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Wednesday, January 17, 2024OPPOSITION PAPERS RECEIVED AT TTAB
Thursday, January 25, 2024OPPOSITION INSTITUTED NO. 999999
Friday, February 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 6, 2024REFUSAL PROCESSED BY IB
Wednesday, October 9, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, October 9, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, October 26, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, March 17, 2025LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Monday, March 17, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, April 17, 2025NON-FINAL ACTION WRITTEN
Friday, April 18, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 18, 2025REFUSAL PROCESSED BY MPU
Friday, April 18, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 30, 2025IRREGULARITY ON REFUSAL FROM IB
Saturday, May 24, 2025REFUSAL PROCESSED BY IB
Monday, November 3, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 3, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

gentitan research services field scientific medical analysis technology biological purposes testing